您要查找的是不是：
- in situ infiltrating reaction 原位渗透反应
- Key around Mobile, the next key stop in situ fixed. 左右键移动,下键停在原地不动。
- Lobular carcinoma in situ is seen here. 图示小叶原位癌。
- Fluorescence in situ hybridization See FISH. 荧光原位杂交：参见FISH.
- RDP＝rumen-degradable protein measured in situ. 经瘤胃消化袋测得之瘤胃可分解蛋白质。
- Biopolymer can be triggered in situ to form a gel. 对生物矿化作用的进一步研究有助于微生物调剖机理的完善和应用。
- In order to study the change of IL 6 and IL 8 in late phase reaction(LPR)of the skin,the technique of in situ hybridizationwas used to identify messenger RNA for IL 6 and IL 8 in cells infiltrating allergen induced LPR of the skin. 为探讨 IL - 6和 IL - 8在皮肤晚期反应 ( L PR)标本中的变化 ,采用原位杂交技术 ,测定了 IL - 6和 IL - 8m RNA在 14例夏季枯草热患者变应原诱导的 L PR标本中的表达。
- The rocks were not in situ; they had been brought from elsewhere. 石块不是原来就在那里的，是从别处搬来的。
- In situ deposits are dark shale with horizontal bedding. 原地沉积为水平层理发育的暗色泥板岩。
- In Situ Hybridization on Vasa Gene of Silkworm Bombyx Mori. 家蚕vasa基因的原位杂交研究
- Fluorescence in situ hybridization (FISH) technique developed. 发明原位免疫荧光杂交(FISH)技术.
- The debate here is probably ADH or ductal carcinoma in situ (DCIS). 这里争论的焦点是ADH还是导管原位癌。
- Methods Immunocytochemistry and in situ hybridization. 方法免疫细胞化学和原位杂交技术。
- It is the first report for in situ cohybridization in plants. 用生物素标记对它们进行了原位单杂交和共杂交的比较定位。
- Expression of P53 oncogene was detected by in situ hybridization . P53基因异常表达采用原位杂交方法。
- Methods: Non-radiative prober is used in hybridization in situ. 方法非放射性探针原位杂交法。
- Laser in situ Keratomileusis Retreatment for Residual Myopia[J]. 引用该论文 沈政伟;尹禾;梅军;吴金桃;李丽;黄震晞.
- The large cells infiltrating into the epidermis represent intraepithelial extension of an underlying ductal carcinoma in situ or invasive ductal carcinoma. 浸润至真皮的大细胞说明位于下方的导管原位癌或浸润性导管癌向上皮内侵犯。
- Methods: Mainly with methods of in situ reverse transcription polymerase chain reaction (In situ RT-PCR). 方法 以原位逆转录聚合酶链式反应(In situ reverse transcription polymerase chain reaction,In situ RT-PCR)为主要研究方法。
- The result showed that within 40 weeks, there were atypical hyperplasia (5, 6, 5, 4 cases separately); carcinoma in situ (3, 1, 1, 1 cases separately); infiltrating carcinoma (1 case in large dose serial DNP and PMA administered group). 在40周内，分别见不典型性增生及异型鳞状化生5、6、6及7例次，原位癌依次为3、1、1及1例，而大剂量DNP＋PMA组及低剂量多次给药组各诱发浸润癌一例。
